HeartGenetics

πŸ“ Cantanhede, PortugalπŸ—“ Founded 2013πŸ‘₯ 20 employeesπŸ’° Last funded Feb 2017
HeartGenetics (www.heartgenetics.com) is a digital health company that adds intelligence to genetic data. Our AI tools are the heart and mind of our own CE-IVD certified HEARTDECODE system for intelligent reporting. Supported by a strong knowledge of cardiovascular genetics, our new wellness genetic tests and apps are instrumental in the definition of highly personalised lifestyle plans and are already impacting thousands of people on a daily basis. Based on more than 20 years of its own cutting-edge research in the cardiovascular field, the HeartGenetics team has developed a set of CE-IVD genetic tests that can be prescribed by healthcare professionals in different specialties, such as Wellness (core), Obstetrics, Cardiology and drug response (Cardio and Cancer).
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2013
Founded
Investor geography1 country
Portugal
3
Investor activity2013–2017 Β· investors recorded per year
201312015120171
Recent (last 2y)Earlier
Frequently asked questions
Who invested in HeartGenetics?
HeartGenetics has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did HeartGenetics last raise funding?
The most recent investment in HeartGenetics recorded on gritt.io was in February 2017.
When was HeartGenetics founded?
HeartGenetics was founded in 2013.
What industry is HeartGenetics in?
HeartGenetics operates in Information Technology & Services. Find similar Information Technology & Services investors on gritt.io.
Where is HeartGenetics based?
HeartGenetics is headquartered in Cantanhede, Portugal.